PROGRAMME

 Thursday, June 28th

Friday, June 29th

Saturday, June 30th

Sunday, July 1st

 

 Friday, June 29th

 


 

09.00-09.10 h. Welcome address
 

Manuel AriasPresident of the Organizing Committee

María-Jesús Sobrido. President of the Scientific Committee

     
09.10-11.00 h. 

Session I: Epidemiological and clinical research

  CHAIR: Ángel Sesar. Neurology Department, University Hospital, Santiago de Compostela, Spain.
     
  09.15 h.    Spinocerebellar ataxias: a historical overview
    José Ángel BercianoCantabria University, Santander, Spain
     
   09.45 h.   

Worldwide epidemiology of SCA36

   

María-Jesús SobridoHealth Research Institute of Santiago de Compostela, Spain

     
   10.05 h.   

SCA36 families from Albacete

    Oscar AyoNeurology Department, University Hospital, Albacete, Spain
     
   10.25 h.    Plenary discussion
     
  10.40 h.    Selected brief communications
    -Cerebellar cognitive-affective syndrome in Costa da Morte ataxia (SCA36)

 Rocío Martínez-Regueiro et al. Institute of Biomedical Research, Santiago de Compostela, Spain

   

-Clinical features of Asidan patients with DWEP

 Yasuyuki Ohta et al. Neurology Department, Okayama University Medical School, Japan

     
11.00-11.25 h.   Coffee break 
     
11.30-11.45 h.  Meeting opening ceremony
  Local authorities
     
11.45-13.45 h.

Session II: Update on clinical research in SCA36 and other ataxias

  CHAIR: Celia Pérez. Neurology Department, University Hospital of A Coruña, Spain
     
   11.45 h.    From the pre-ataxic stage to clinical follow-up of Costa da Morte ataxia
   

Manuel Arias. Neurology Department, University Hospital, Santiago de Compostela, Spain

     
  12.10 h.    SCA37: From bedside to pathology and molecular basis
    Carmen Serrano. Manresa-Bages University Foundation, Barcelona, Spain
     
   12.35 h.    Neurotology of Ataxias
    Joanna Jen Icahn School of Medicine at Mount Sinai, New York, U.S.A.
     
   13.00 h.    Evaluation and treatment of balance impairment in SCA36
    Andrés Soto. ENT- Department, University Hospital, Santiago de Compostela, Spain
     
   13.25 h.    Plenary discussion
     
13.45-15.30 h.  Lunch and poster viewing
     
   

Frequency and structure of the SCA36-associated haplotype in Galicia

Beatriz Quintáns et al. Health Research Institute of Santiago de Compostela, Spain

     
   

SCAs and epilepsy: description of two cases

Carlos Cores-Bartolomé et al. Neurology Department, University Hospital, A Coruña, Spain

     
   

Transverse epidemiological study of hereditary ataxias and spastic paraplegias in Spain

Mª José Abenza-Abildúa et al. Neurology Department, Infanta Sofia University Hospital, San Sebastián de los Reyes, Spain

     
   

Zebrafish models in the study of ataxias

Ana Quelle-Regaldie et al. Biomedical Experimental Center of Galicia, Santiago de Compostela, Spain.

     
   

Clinical usefulness of plasma microRNA-15a-5p as a marker for early diagnosis in Alzheimer 's disease

Laura Rojas-Bartolomé et al. Neurology Department, University Hospital, Albacete, Spain

     
   

A Spanish myotonic dystrophy type I family carrying interruptions showing a milder and atypical phenotype

Ian Linares et al.Institute of Biomedical Research Germans Trias I Pujol, Badalona, Spain

     
15.30-17.40 h. 

 Session III: Neuropathology and pathomechanisms of SCA36

  CHAIR: Joanna Jen. Mount Sinai Hospital, St. Luke's, New York, USA
     
   15.30 h.    Clinical characteristics of a novel ALS/SCA crossroad mutation Asidan (SCA36)
    Koji Abe. Okayama University Medical School, Japan
     
  16.00 h.    Neuropathology of SCA36-Ataxia da Costa da Morte
   

Beatriz San Millán. Pathology Department, Complexo Hospitalario Universitario, Vigo, Spain

     
  16.25 h.    Di-peptide repeat pathology in SCA36 
   

Wilfried Rossoll. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA

Zachary Mceachin. Emory University, Atlanta, USA

     
  17.05 h.    Plenary discussion
     
  17.20 h.    Selected brief communications
   

-Molecular characterization of toxic PR poly-dipeptides encoded by C9orf72 repeat expansion

 Eiichiro Mori et al. Department of Future Basic Medicine and Neurology, Nara Medical University, Japan

    -Clinical characterization of Asidan in Japan

 Toru Yamashita et al. Neurology. Department, Okayama University Medical School, Japan

     
17.40-18.00 h.  Coffee break
     
18.00-19.45 h. 

 Session IV: Cellular and animal models in SCA36 and related disorders

  CHAIR: Mar Castellanos. Neurology Department, Complexo Hospitalario Universitario, A Coruña, Spain
     
  18.00 h.    SCA37: another repeat-insertion causing ataxia
   

Isabel Silveira. Instituto de Biologia Molecular e Celular, Porto, Portugal

     
   18.30 h.    Expression of an expanded TG3C2 repeat in mice results in a SCA36-like phenotype
   

Leonard Petruccelli. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA

     
  19.00 h.    Zebrafish models of ataxias
   

Laura Sánchez-Piñón.  Genetics Department, Veterinary School Lugo, University of Santiago de Compostela, Spain

     
  19.30 h.    Plenary discussion
     
21.30-24.00 h.  Dinner
     
     

 

 

 

 

 

 

      TECHNICAL SECRETARIAT: Orzan Congres | Phone +34 981 900 700 | Email: SCA36Symposium2018@orzancongres.com